Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Canntab Therapeutics Ltd (PILL.CN)

Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 195
  • Shares Outstanding, K 38,909
  • Annual Sales, $ 293 K
  • Annual Income, $ -3,689 K
  • 60-Month Beta 0.22
  • Price/Sales 2.65
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PILL.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings $-0.01 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend 2.900 on 03/08/16
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0050 unch
on 10/06/23
0.0100 -50.00%
on 10/02/23
-0.0050 (-50.00%)
since 09/06/23
3-Month
0.0050 unch
on 10/06/23
0.0200 -75.00%
on 07/27/23
-0.0150 (-75.00%)
since 07/06/23
52-Week
0.0050 unch
on 10/06/23
0.1150 -95.65%
on 10/07/22
-0.1100 (-95.65%)
since 10/06/22

Most Recent Stories

More News
Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order

Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the "Corporation") announces that the Ontario Securities Commission (the...

CTABF : 0.0073 (+356.25%)
PILL.CN : 0.0050 (unch)
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET

/CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
Canntab Corporate Update

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
Canntab Corporate Update

/CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
Canntab Engages Hamish Sutherland as Strategic Advisor

/CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends...

PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
Proactive news headlines including Kintara Therapeutics, NEXE Innovations, LexaGene Holdings and Mindset Pharma

New York , June 03, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

KTRA : 0.1680 (+7.01%)
NEXNF : 0.2681 (+9.88%)
LXXGF : 0.0806 (-16.48%)
RFR.CN : 0.0150 (unch)
RFHRF : 0.0137 (+7.03%)
AGN.CN : 0.1600 (unch)
AGNPF : 0.1163 (-2.60%)
CBDHF : 0.0002 (+100.00%)
PEMC : 0.0002 (unch)
PEMSF : 0.0375 (+7.14%)
NEXCF : 0.0901 (-9.90%)
NTAR.CN : 0.1300 (-3.70%)
Proactive news headlines including Vuzix Corporation, American Battery Metals, BioSig Technologies and Canntab Therapeutics

Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies

VUZI : 1.5600 (+0.65%)
AREC : 1.2550 (-0.40%)
TOMDF : 0.0001 (unch)
VST.CN : 0.1050 (unch)
VSQTF : 0.0747 (+1.77%)
STPGF : 0.4863 (-0.76%)
IP.CN : 0.0450 (+12.50%)
IPNFF : 0.0256 (-11.72%)
ABML : 9.8300 (unch)
BRAG : 6.00 (+0.84%)
BRGGF : 10.3800 (-4.50%)
CNI.CN : 0.1100 (-15.38%)
Proactive news headlines including NetCents Technology, Canntab Therapeutics, Pacific Empire Minerals and Medallion Resources

Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

NC.CN : 0.690 (unch)
NTTCF : 0.0001 (unch)
PILL.CN : 0.0050 (unch)
CTABF : 0.0073 (+356.25%)
OIIIF : 1.0020 (-1.76%)
PEMC : 0.0002 (unch)
PEMSF : 0.0375 (+7.14%)
MLLOF : 0.0770 (+8.91%)
MRDN : 0.60 (-4.76%)
CBDHF : 0.0002 (+100.00%)
ORGS : 0.4800 (-1.03%)
CANN.CN : 0.0050 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective...

See More

Key Turning Points

3rd Resistance Point 0.0050
2nd Resistance Point 0.0050
1st Resistance Point 0.0050
Last Price 0.0050
1st Support Level 0.0050
2nd Support Level 0.0050
3rd Support Level 0.0050

See More

52-Week High 0.1150
Fibonacci 61.8% 0.0730
Fibonacci 50% 0.0600
Fibonacci 38.2% 0.0470
Last Price 0.0050
52-Week Low 0.0050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar